搜尋結果
Here Are the Obesity Drug Hopefuls Vying to Unseat Ozempic, Zepbound
Bloomberg· 3 日前Insatiable demand for weight-loss drugs has made the market so feverish that any positive ...
Jim Cramer's top 10 things to watch in the stock market Friday
CNBC· 3 日前My top 10 things to watch Friday, May 3 The Dow , the S & P 500 and the Nasdaq set to surge at ...
Amgen Knocks Novo Nordisk's Ozempic Stock Rally. Its Stock Is Flying.
The Wall Street Journal· 3 日前Amgen’s progress on its experimental weight-loss drug offered investors a reminder that Novo Nordisk ...
Novo Nordisk drops 5% after rival Amgen teases weight-loss drug data
Reuters· 3 日前Shares in Danish drugmaker Novo Nordisk dropped as much as 5.3% on Friday, set for their ...
Novo Slides as Amgen Fuels Obesity Drug Competition Fears
Bloomberg· 3 日前... reporters? Novo Nordisk A/S shares fell as a US rival’s comments on an experimental ... ...
Pastry Chefs in Paris Are Dreaming Up Delightful Twists on Classics
Bloomberg· 3 日前The seven treats that are upending the city’s baking hierarchy.
Slowing ALS Progression Through Gene Therapy
Forbes· 3 日前This story is part of a series on the current progression in Regenerative Medicine. In 1999, I ...
Amgen 'encouraged' by weight-loss drug interim data, shares jump
Reuters· 4 日前, opens new tab on Thursday said it was very encouraged after completing an interim analysis of ...
Amgen Soars as CEO Touts Experimental Obesity Drug Progress
Bloomberg· 4 日前Amgen Inc.’s shares soared after its chief executive officer said he was “very encouraged” by ...
Stocks making the biggest moves after hours: Apple, Cloudflare, Expedia, Block and more
CNBC· 4 日前These are the stocks posting the largest moves in extended trading.